Phase II results support further study of AAV2-REP1 gene therapy in patients with choroideremia Sep. 9, 2019 No Comments
Novel Chemerin GPCR agonist OK-113 exhibits anti-inflammatory activity in DED mouse model Aug. 30, 2019 No Comments
Aerie initiates first-in-human study of AR-13503 sustained-release intravitreal Implant Aug. 21, 2019 No Comments
Oxurion reports topline results from phase IIa study of THR-317 plus ranibizumab in DME Aug. 20, 2019 No Comments
Kala Pharmaceuticals receives FDA complete response letter for KPI-121 0.25% Aug. 9, 2019 No Comments
RSS